ArticleIndian journal of endocrinology and metabolism

Efficacy and Safety of Novel Dipeptidyl-Peptidase-4 Inhibitor Evogliptin in the Management of Type 2 Diabetes Mellitus: A Meta-Analysis.

Deep Dutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.